Gemoscan Canada Announces Closing of Convertible Debenture Financing

Gemoscan Canada, Inc. ("Gemoscan" or the "Corporation") (TSX VENTURE:GES)
(MUN:1GE) wishes to announce that, subject to TSX Venture Exchange ("TSXV")
final approval, it has completed closing its convertible debenture financing,
announced August 3, 2012, with total proceeds of $142,000. The debentures will
have a term of one (1) year and pay interest at the rate of 8% per annum. The
debentures will be unsecured. The debentures will be convertible into shares of
the Corporation at the rate of one Class A share for each $0.27 converted. In
addition, purchasers shall receive one-half of a share purchase warrant for each
$0.27 in debenture acquired Each full warrant will entitle the holder to acquire
a Class A share at a price of $0.27 per share until August 20, 2013.


All securities issued pursuant to the above referenced private placement are
subject to a statutory four month plus one day hold period from closing and
regulatory approval.


The proceeds from the offering will be used for working capital purposes.

ABOUT GEMOSCAN CANADA, INC. 

Gemoscan is an industry leader in food intolerance management and maintains a
first-to-market position with Canada wide distribution through select retail
partners. Founded in 2003, using its proprietary patented technology; Gemoscan
develops, owns and markets comprehensive food sensitivity and dietary management
solutions for consumers, including the HEMOCODETM Food Intolerance System, a
personalized naturopathic nutritional program that promotes well-being. Gemoscan
is the first and only provider to commercialize a food intolerance management
solution directly to consumers in partnership with retailers, and today offers
the most comprehensive services available.


Gemoscan Canada, Inc. trades its shares on the Toronto Venture Exchange (TSX-V)
under the symbol GES and is quoted on the Munich, Frankfurt and Stuttgart Stock
Exchanges under the symbol 1GE.


Forward-Looking Information 

This news release contains certain "forward-looking information". All
statements, other than statements of historical fact that address activities,
events or developments that Gemoscan believes, expects or anticipates will or
may occur in the future. These forward-looking statements reflect the current
expectations or beliefs of Gemoscan based on information currently available to
Gemoscan. Forward-looking statements are subject to a number of significant
risks and uncertainties and other factors that may cause the actual results of
Gemoscan to differ materially from those discussed in the forward-looking
statements, and even if such actual results are realized or substantially
realized, there can be no assurance that they will have the expected
consequences to, or effects on Gemoscan. Any forward-looking statement speaks
only as of the date on which it is made and, except as may be required by
applicable securities laws, Gemoscan disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new information,
future events or results or otherwise. Although Gemoscan believes that the
assumptions inherent in the forward-looking statements are reasonable,
forward-looking statements are not guarantees of future performance and
accordingly undue reliance should not be put on such statements due to the
inherent uncertainty therein.

Gemoscan Canada, Inc. (TSXV:GES)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024